Luc Lammens graduated as Master in Scientific Applied Economics, with specialization in International Business Affairs (K.U. Leuven 1988).
He is consultant for innovative, start up and early stage companies with an international profile. He is in charge of specific financial missions such as in Apitope, Multiplicom and Etherna.
Amongst these he contributed to the start-up, financial long term planning, IFRS conversion, audit preparations and successful IPO of Movetis (100M€). He had a pivotal role in relocating the Biocartis R&D and Manufacturing from Lausanne to Flanders in collaboration with VIB/FIT. He applied successfully for IWT and EU R&D funding. He serves as a board member of Progress Pharma. He is contributing to the Intellectual Property Policy of the Institute for Tropical Medicine.
Previously, he was during 10 years active at Janssen Pharmaceutica nv. Primarily as a financial analyst for in-licensing agreements and pharma P&L. Prior to that, he was member of the business development group from the Belgian-Chinese Joint-Venture: Xian-Janssen.
He started his career with a European sugar producer (Tiense Suikerraffinaderij - Südzuker) and a large London trading company (E.D. & F. Man).
He is the author of three books on Business Plan, Financial Plan and Venture Capital. He is a member of the Institute of Directors (U.K.) and the Belgian Luxembourg Business Group (Singapore).
Christel Verleyen graduated as Master in Law (K.U. Leuven 1986) and Master in Intellectual Property (K.U. Brussels).
She is lawyer at the Brussels Bar as well as in Bruges. Since 2003 she became active in international law and intellectual property law. Her experience was built up through practical cases while being in charge of law firms as well as technology ventures.
BUSINESS PARTNER IN SINGAPORE
Founder Manager Jama Corporate Secretarial Pte Ltd. – ex KPMG Singapore